CH678599A5 - - Google Patents
Download PDFInfo
- Publication number
- CH678599A5 CH678599A5 CH3749/87A CH374987A CH678599A5 CH 678599 A5 CH678599 A5 CH 678599A5 CH 3749/87 A CH3749/87 A CH 3749/87A CH 374987 A CH374987 A CH 374987A CH 678599 A5 CH678599 A5 CH 678599A5
- Authority
- CH
- Switzerland
- Prior art keywords
- pro
- injection
- urokinase
- infusion
- administered
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/49—Urokinase; Tissue plasminogen activator
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB868623823A GB8623823D0 (en) | 1986-10-03 | 1986-10-03 | Therapeutic lysis of fibrin blood clots |
| GB868628741A GB8628741D0 (en) | 1986-12-02 | 1986-12-02 | Therapeutic lysis of fibrin blood clots |
| GB878707551A GB8707551D0 (en) | 1987-03-30 | 1987-03-30 | Therapeutic lysis of fibrin blood clots |
| GB878715678A GB8715678D0 (en) | 1987-07-03 | 1987-07-03 | Therapeutic lysis of fibrin blood clots |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH678599A5 true CH678599A5 (enExample) | 1991-10-15 |
Family
ID=27449820
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH3749/87A CH678599A5 (enExample) | 1986-10-03 | 1987-09-28 |
Country Status (19)
| Country | Link |
|---|---|
| KR (1) | KR960002738B1 (enExample) |
| AU (1) | AU7932587A (enExample) |
| BE (1) | BE1002058A4 (enExample) |
| CA (1) | CA1323300C (enExample) |
| CH (1) | CH678599A5 (enExample) |
| DE (1) | DE3731776A1 (enExample) |
| DK (1) | DK519287A (enExample) |
| FI (1) | FI874320L (enExample) |
| FR (1) | FR2605225B1 (enExample) |
| GR (1) | GR871528B (enExample) |
| HU (1) | HUT47032A (enExample) |
| IL (1) | IL84061A0 (enExample) |
| IT (1) | IT1230114B (enExample) |
| LU (1) | LU87007A1 (enExample) |
| MY (1) | MY101943A (enExample) |
| NL (1) | NL8702234A (enExample) |
| NO (1) | NO874143L (enExample) |
| PT (1) | PT85848B (enExample) |
| SE (1) | SE466531B (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL8503097A (nl) * | 1985-11-11 | 1987-06-01 | Leuven Res & Dev Vzw | Geneesmiddel met thrombolytische werking. |
-
1987
- 1987-09-18 HU HU874172A patent/HUT47032A/hu unknown
- 1987-09-18 NL NL8702234A patent/NL8702234A/nl not_active Application Discontinuation
- 1987-09-22 DE DE19873731776 patent/DE3731776A1/de not_active Ceased
- 1987-09-28 BE BE8701102A patent/BE1002058A4/fr active
- 1987-09-28 CH CH3749/87A patent/CH678599A5/de not_active IP Right Cessation
- 1987-09-28 FR FR8713486A patent/FR2605225B1/fr not_active Expired - Fee Related
- 1987-10-01 NO NO874143A patent/NO874143L/no unknown
- 1987-10-01 SE SE8703788A patent/SE466531B/sv not_active IP Right Cessation
- 1987-10-01 CA CA000548421A patent/CA1323300C/en not_active Expired - Fee Related
- 1987-10-01 FI FI874320A patent/FI874320L/fi not_active IP Right Cessation
- 1987-10-01 IL IL84061A patent/IL84061A0/xx unknown
- 1987-10-01 LU LU87007A patent/LU87007A1/fr unknown
- 1987-10-01 GR GR871528A patent/GR871528B/el unknown
- 1987-10-01 PT PT85848A patent/PT85848B/pt unknown
- 1987-10-02 DK DK519287A patent/DK519287A/da not_active Application Discontinuation
- 1987-10-02 AU AU79325/87A patent/AU7932587A/en not_active Abandoned
- 1987-10-02 IT IT8748444A patent/IT1230114B/it active
- 1987-10-02 KR KR1019870011020A patent/KR960002738B1/ko not_active Expired - Fee Related
- 1987-10-08 MY MYPI87002871A patent/MY101943A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO874143D0 (no) | 1987-10-01 |
| IT8748444A0 (it) | 1987-10-02 |
| BE1002058A4 (fr) | 1990-06-12 |
| FI874320A7 (fi) | 1988-04-04 |
| MY101943A (en) | 1992-02-15 |
| IT1230114B (it) | 1991-10-07 |
| SE8703788L (sv) | 1988-04-04 |
| KR880004821A (ko) | 1988-06-27 |
| DK519287D0 (da) | 1987-10-02 |
| LU87007A1 (fr) | 1988-05-03 |
| AU7932587A (en) | 1988-04-14 |
| NL8702234A (nl) | 1988-05-02 |
| GR871528B (en) | 1988-02-23 |
| KR960002738B1 (ko) | 1996-02-26 |
| FR2605225A1 (fr) | 1988-04-22 |
| PT85848B (en) | 1990-01-12 |
| DK519287A (da) | 1988-04-04 |
| FI874320A0 (fi) | 1987-10-01 |
| SE8703788D0 (sv) | 1987-10-01 |
| CA1323300C (en) | 1993-10-19 |
| FR2605225B1 (fr) | 1994-02-04 |
| PT85848A (en) | 1987-11-01 |
| IL84061A0 (en) | 1988-03-31 |
| HUT47032A (en) | 1989-01-30 |
| FI874320L (fi) | 1988-04-04 |
| SE466531B (sv) | 1992-03-02 |
| DE3731776A1 (de) | 1988-05-05 |
| NO874143L (no) | 1988-04-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69503120T3 (de) | Zusammensetzungen aus einer thrombolytisch wirkende substanz und antikoagulantien, und ihre verwendungen | |
| DE69130289T2 (de) | Therapeutische verwendung von actin-bindenden verbindungen | |
| DE69828462T2 (de) | Verwendung von APC, in Kombination mit Blutplättchenaggregationshemmer, zur Behandlung thrombothischer Störungen | |
| DE69429429T2 (de) | MODIFIZIERTER FAKTOR VII zur Hemmung der vaskulären Restenosis und Thrombozytenablagerung | |
| DE3689943T2 (de) | Degradierte Spezies eines Gewebeplasminogenaktivators, pharmazeutische Zubereitung und Verfahren zur Herstellung derselben. | |
| DE69325393T2 (de) | Pharmazeutische zusammensetzungen und verfahren unter verwendung von isobutyramid zur behandlung von betaglobinerkrankungen | |
| DE4411143C2 (de) | Thrombosemittel | |
| DE3876348T2 (de) | Thrombolytisches agens. | |
| EP1622639B1 (de) | Intravenöse injektion nicht-neurotoxischer plasminogen-aktivatoren zur behandlung von schlaganfall | |
| EP0625908B1 (de) | Antidot für hirudin und synthetische thrombininhibitoren | |
| EP1308166B1 (de) | Nicht-neurotoxische Plasminogen Aktivierende Faktoren zur Behandlung von Schlaganfällen | |
| US5055295A (en) | Lysis of fibrin blood clots with urokinase and pro-urokinase | |
| DE60301862T2 (de) | Kombinationsbehandlung bei akutem myokardinfarkt | |
| DE69317343T2 (de) | Verwendung eines direkten Inhibitors von Thrombin zur Herstellung eines Arzneimittels mit thrombolytischer Aktivität | |
| DE69905489T2 (de) | Protein c zur behandlung von sichelzellanämie und thalassämie | |
| DE69532123T2 (de) | Thrombolytische zusammensetzungen | |
| CH678599A5 (enExample) | ||
| DE69000290T2 (de) | Thrombotische zusammensetzungen. | |
| EP0458929B1 (de) | t-PA-Solubilisierung | |
| DE69724818T2 (de) | Medizinische Verwendung des scuPA/suPAR Komplexes | |
| DE68908716T2 (de) | Heparin enthaltende formulierungen. | |
| DE60004185T2 (de) | Supar stimulierende aktivität auf die tcupa vermittelte fibrinolyse und verschiedene verwendungen davon | |
| DE3586795T2 (de) | Absorptionsverbesserer fuer proteine. | |
| EP0733371B1 (de) | Mittel zur subkutanen Verabreichung von Protein C | |
| DE60225576T2 (de) | Verfahren zur unterdrückung der bildung von seromen mit faktor xiii |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased |